Lakewood-Amedex Biotherapeutics, Inc.

Lakewood-Amedex Biotherapeutics, Inc. (LABT) — Form 10-Q: Quarterly report

10-QLABTFiled Aug 13, 2026, 5:36 PM ET· Period Jun 30, 2026

About this filing

Lakewood-Amedex Biotherapeutics, Inc. (LABT) filed Form 10-Q (quarterly report) with the SEC on Aug 13, 2026. A 10-Q is the company’s quarterly financial report.

View original filing on SEC.gov

Key facts

Document: QUARTERLY REPORT

More LABT filings

8-K
Current report
Filed Sep 28, 2026
EFFECT
SEC filing
Filed Sep 24, 2026
S-1
Registration statement
Filed Sep 18, 2026
DRS
SEC filing
Filed Aug 21, 2026
424B3
Prospectus
Filed Aug 17, 2026
SC 13G
Ownership over 5% (passive)
Filed Aug 14, 2026

Not investment advice. Summaries can contain errors; the SEC filing is the official record.